Product
valprote
1 clinical trial
1 indication
Indication
Bipolar disorderClinical trial
Clinical Efficacy and Safety of Vortioxetine Combined With Mood Stabilizer in the Treatment of Bipolar Disorder Type II DepressionStatus: Completed, Estimated PCD: 2023-06-28